Myriad Genetics (MYGN) Cash & Current Investments (2009 - 2026)
Myriad Genetics (MYGN) posted quarterly Cash & Current Investments of $124.4 million for Q1 2026, up 35.51% year-over-year from $91.8 million in Q1 2025, and down 16.84% quarter-over-quarter from $149.6 million in Q4 2025.
Myriad Genetics (MYGN) Cash & Current Investments (2009 - 2026) Analysis & Trends
Myriad Genetics (MYGN) has reported Cash & Current Investments for 18 consecutive years, with $124.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash & Current Investments rose 35.51% year-over-year to $124.4 million; the TTM figure through Mar 2026 stood at $124.4 million (up 35.51% YoY), while the FY2025 annual figure was $149.6 million, up 46.09% from the prior year.
- Cash & Current Investments eased to $124.4 million in Q1 2026 per MYGN's latest filing, from $149.6 million in the prior quarter.
- Across five years, Cash & Current Investments topped out at $267.4 million in Q1 2022 and bottomed at $74.4 million in Q2 2025.
- Historically, Cash & Current Investments has averaged $129.1 million across 5 years, with a median of $114.9 million in 2022.
- Annual changes were most pronounced in 2022 — Cash & Current Investments jumped 51.85% — and 2023, when it plunged 70.57%.
- Myriad Genetics' Cash & Current Investments stood at $114.9 million in 2022, then climbed by 22.63% to $140.9 million in 2023, then dropped by 27.32% to $102.4 million in 2024, then jumped by 46.09% to $149.6 million in 2025, then slipped by 16.84% to $124.4 million in 2026.
- Business Quant data shows MYGN's Cash & Current Investments at $124.4 million in Q1 2026, $149.6 million in Q4 2025, and $145.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 4.06 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 4.35 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 196.93 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 1.81 Bn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 2.08 Bn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 1.10 Bn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 1.17 Bn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 51.40 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 626.00 Mn |
| 10 | Myriad Genetics | 297.97 Mn | 173.57 Mn | 137.60 Mn | 124.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 124.40 Mn |
| Dec 31, 2025 | 149.60 Mn |
| Sep 30, 2025 | 145.40 Mn |
| Jun 30, 2025 | 74.40 Mn |
| Mar 31, 2025 | 91.80 Mn |
| Dec 31, 2024 | 102.40 Mn |
| Sep 30, 2024 | 99.90 Mn |
| Jun 30, 2024 | 97.30 Mn |
| Mar 31, 2024 | 104.30 Mn |
| Dec 31, 2023 | 140.90 Mn |
| Sep 30, 2023 | 86.30 Mn |
| Jun 30, 2023 | 121.60 Mn |
| Mar 31, 2023 | 78.70 Mn |
| Dec 31, 2022 | 114.90 Mn |
| Sep 30, 2022 | 191.20 Mn |
| Jun 30, 2022 | 204.10 Mn |
| Mar 31, 2022 | 267.40 Mn |
| Dec 31, 2021 | 338.80 Mn |
| Sep 30, 2021 | 366.10 Mn |
| Jun 30, 2021 | 164.40 Mn |